title: KS1/4-DAVLB, a monoclonal antibody-vinca alkaloid conjugate for site-directed therapy of epithelial malignancies.
authors.affiliation: Lilly Research Laboratories, Indianapolis, Indiana.
authors.forename: T F
authors.initials: TF
authors.lastname: Bumol
authors.forename: A L
authors.initials: AL
authors.lastname: Baker
authors.forename: E L
authors.initials: EL
authors.lastname: Andrews
authors.forename: S V
authors.initials: SV
authors.lastname: DeHerdt
authors.forename: S L
authors.initials: SL
authors.lastname: Briggs
authors.forename: M E
authors.initials: ME
authors.lastname: Spearman
authors.forename: L D
authors.initials: LD
authors.lastname: Apelgren
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000302:isolation & purification / Q000627:therapeutic use; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use*; D051379:Mice; D008819:Mice, Nude; D009369:Neoplasms / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D014183:Transplantation, Heterologous; D014748:Vinca Alkaloids / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000911:Antibodies, Monoclonal; D000922:Immunotoxins; D014748:Vinca Alkaloids